Back to search

Article

Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1

2023-08-23

Abstract excerpt

<h4>Background: </h4> Due to the high drug resistance of hepatocellular carcinoma (HCC), Sorafenib has limited efficacy in the treatment of advanced HCC. Cancer-associated fibroblasts (CAFs) play an important regulatory role in the induction of chemo-resistance. This study aimed to clarify the mechanism underlying CAF-mediated resistance to sorafenib in HCC. <h4>Methods: </h4>: Immunohistochemistry and immunofluo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
88794111-073b-5f43-bbd6-750a99a40cd5
DOI
10.21203/rs.3.rs-3152222/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1DOI 10.21203/rs.3.rs-3152222/v1
Select a neighboring publication to make it the new centre.